Brett Brodnax Named CEO of USPI

Go back to Brett Brodnax Named CEO of USPI

Tenet Healthcare (THC) PT Lowered to $32 at Mizuho Securities

November 8, 2018 8:38 AM EST

Mizuho Securities analyst Ann Hynes lowered the price target on Tenet Healthcare (NYSE: THC) to $32.00 (from $36.00) while maintaining a Buy rating following the company's 3Q results. THC's mixed results drew some concerns on Hospital business due to headwinds from malpractice and risk-based contracts.... More